Oscar Health, Inc. (OSCR) Stock
NYSE · OSCR
29.89
Fundamentals
Market cap
$9.14B
Price / Earnings ratio
16.2x
Price / Sales ratio
0.6x
Price / Book ratio
4.3x
Return on assets
-1.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Best Growth Stocks to Buy for September 25th
NeutralOSCRSeptember 25, 2026
Zacks Investment ResearchNeutral
Best Growth Stocks to Buy for September 25th
OSCR

Zacks Investment Research
Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?
NeutralOSCRSeptember 23, 2026
Zacks Investment ResearchNeutral
Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?
OSCR

Zacks Investment Research
All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy
NeutralOSCRSeptember 23, 2026
Zacks Investment ResearchNeutral
All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy
OSCR

Zacks Investment Research
Best Momentum Stocks to Buy for September 23rd
NeutralOSCRSeptember 23, 2026
Zacks Investment ResearchNeutral
Best Momentum Stocks to Buy for September 23rd
OSCR
Technicals
OscillatorsStrong Sell5 Indicators
Moving AveragesSell12 Indicators
Analyst Ratings
Strong Sell0
Sell1
Neutral4
Buy2
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2025
14B9B5B0
Debt & Balance Sheet
Total assets
Total liabilities
2025
8B5B3B0
Revenue to Profit
2025$11.7B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$-443.2M
Net incomeEarnings
EPS forecast
Actual EPS
$-0.89
$-0.86
Q2FY25
$-0.53
$-0.57
Q3FY25
$-0.89
Q4FY25
$0.75
Q1FY26
$-0.16
Q2FY26
The market is expecting earnings per share of -$0.16 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Best Growth Stocks to Buy for September 25th
NeutralOSCRSeptember 25, 2026
Zacks Investment ResearchNeutral
Best Growth Stocks to Buy for September 25th
OSCR

Zacks Investment Research
Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?
NeutralOSCRSeptember 23, 2026
Zacks Investment ResearchNeutral
Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise?
OSCR

Zacks Investment Research
All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy
NeutralOSCRSeptember 23, 2026
Zacks Investment ResearchNeutral
All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy
OSCR

Zacks Investment Research
Best Momentum Stocks to Buy for September 23rd
NeutralOSCRSeptember 23, 2026
Zacks Investment ResearchNeutral
Best Momentum Stocks to Buy for September 23rd
OSCR

Zacks Investment Research
Best Growth Stocks to Buy for September 23rd
NeutralOSCRSeptember 23, 2026
Zacks Investment ResearchNeutral
Best Growth Stocks to Buy for September 23rd
OSCR

Zacks Investment Research
5 Top Multi-Line Insurance Stocks to Buy as Interest Rates Stay Higher
NeutralOSCRSeptember 21, 2026
Zacks Investment ResearchNeutral
5 Top Multi-Line Insurance Stocks to Buy as Interest Rates Stay Higher
OSCR

Zacks Investment Research
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
NeutralOSCRSeptember 21, 2026
Zacks Investment ResearchNeutral
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
OSCR

Zacks Investment Research
Best Growth Stocks to Buy for September 21st
NeutralOSCRSeptember 21, 2026
Zacks Investment ResearchNeutral
Best Growth Stocks to Buy for September 21st
OSCR

Business Wire
Oscar Health Announces Thrive Capital's Completion of Oscar Health Common Stock Distribution to its Limited Partners
NeutralOSCRSeptember 19, 2026
Business WireNeutral
Oscar Health Announces Thrive Capital's Completion of Oscar Health Common Stock Distribution to its Limited Partners
OSCR

Zacks Investment Research
Despite Fast-paced Momentum, Oscar Health (OSCR) Is Still a Bargain Stock
NeutralOSCRSeptember 18, 2026
Zacks Investment ResearchNeutral
Despite Fast-paced Momentum, Oscar Health (OSCR) Is Still a Bargain Stock
OSCR
About Oscar Health, Inc.
Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.
SectorHealthcare
IndustryHealthcare Plans
Employees2,305
CEOMr. Mark Thomas Bertolini
IPO DateMar 3, 2021
HeadquartersNew York, NY
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Mark Thomas Bertolini | CEO & Director | 1957 |
| Mr. Joshua Kushner | Co-Founder & Vice Chairman | 1985 |
| Mr. Mario Tobias Schlosser | Co-Founder, Advisor to the CEO & Director | 1979 |
| Mr. Richard Scott Blackley CPA | Chief Financial Officer | 1968 |
| Mr. Adam McAnaney | EVP & Chief Legal Officer | 1977 |
| Ms. Janet Ann Liang | EVP & President of Oscar Insurance | 1968 |
| Ms. Victoria Baltrus | Chief Accounting Officer | 1970 |
| Chris Potochar | Vice President of Treasury & Investor Relations | — |
| Ms. Rebecca Krouse | Chief People Officer | — |
| Mr. Joel I. Klein J.D. | Senior Advisor | 1947 |
Fundamentals
Valuation
Market cap$9.14B
Price-to-sales ratio0.58
Price-to-book value4.34
Price-earnings ratio16.20
Return on Equity-3.00%
Return on Sales0.00%
Return on Assets-1.00%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$1.61
Income Statement
Average volume5,400,494
EBITDA$19.39M
1 year high (52w)$34.48
1 year low (52w)$10.69
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsStrong Sell5 Indicators
Moving AveragesSell12 Indicators
What the experts say
7 Wall Street Analyst Ratings
HOLD
29% Buy
57% Hold
14% Sell
Target price
$34.43
Est return
16.31%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -1.0 | -2.1 | -47.5 | -8.7 | ||||||||
| 2022 | -17.6 | +5.5 | +37.0 | -27.4 | -35.8 | -9.6 | +18.2 | +23.9 | -18.3 | -24.5 | -23.4 | -15.5 |
| 2023 | +56.1 | +43.9 | +28.7 | -0.1 | +6.7 | +8.5 | -7.2 | -16.3 | -15.3 | -8.1 | +70.7 | +8.8 |
| 2024 | +37.6 | +22.3 | -10.3 | +18.2 | +15.0 | -17.6 | +11.4 | +1.3 | +18.1 | -18.6 | -1.8 | -27.1 |
| 2025 | +22.5 | -12.8 | -13.1 | +0.3 | +5.7 | +50.4 | -31.3 | +22.7 | +15.2 | -4.8 | +1.8 | -13.7 |
| 2026 | -4.1 | -2.6 | -18.0 | +57.4 | +20.2 | +24.2 | -2.1 | -2.5 | -0.8 |



